Watson Restructures Management; Sees Sales Rise On Generic Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
On the heels of announcing that it will acquire Iceland’s Actavis, Watson reports strong sales growth due to generic versions of Lipitor, Concerta and Lovenox.